Fullstack Developer - Vue / Typescript (6591)

This role is for a Fullstack Developer with Vue / Typescript experience on the frontend and .NET/C# experience on the backend.

As part of the StudyHub Product suite, we are working across multiple value streams catering to different user needs – for this role, you will be part of the Strategic Design & Planning suite, focusing on the early design and planning part of clinical trials. We have a tech team of 6 developers, including one tech lead, whom you will be working with.

The organization around this Product suite is new from January as we consolidate products that have lived in somewhat isolation. Initially, we will focus on reducing complexity and simplifying the previous setup. The infrastructure part is fairly well established; for the frontend and backend, we will explore how to work across previously multiple codebases. If monorepositories, micro-frontends, simplification, modules, event driven architecture, and Azure infrastructure interest you, then you will find it here.

We will utilize an internal Container platform for deploying services and APIs, and expect to set up pipelines and platform capabilities for the Product Teams, providing them an out-of-the-box approach to deploy their BFF APIs.

StudyHub is centered around the process of planning Clinical Trials, with major value drivers lying within the Data and Insights provided to the business users who do the actual planning work.

Experience within Pharma is a plus, but not a hard requirement. We require expertise in C#/.NET, VueJs, Typescript, Azure, Azure DevOps, Pipelines (yaml), Container/Docker, API / OpenAPI, and EDA. We are looking for very senior profiles.

The project will initially focus primarily on backend work, but we seek a fullstack developer, as frontend tasks using VueJs and TypeScript will also be needed.

Key Requirements

• C#

• .NET

• VueJs

• Typescript

• Azure

• Azure DevOps

• EDA
  
  

Location: Søborg

Allocation: Full-time 100%

Start date: 02.02.2026

End date: 31.12.2026 (possibility of extension)